Rubeosis Iridis
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis (NCT02641457) | Instituto de Olhos de Goiania | 2014-03-01 |
| Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery (NCT01069341) | Bhagat, Neelakshi, M.D., M.P.H. | 2007-07-01 |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy (NCT00470977) | Manhattan Eye, Ear & Throat Hospital | 2007-05-01 |
| Intraocular Bevacizumab (Avastin) for Rubeosis Iridis (NCT00557232) | Instituto de Olhos de Goiania | 2006-11-01 |
Track Rubeosis Iridis automatically
Every clearance here is in the API, with alerts when new ones post.